Comparison between ABP 234 and Keytruda® (Pembrolizumab)

2024-514304-14-00 Protocol 20210033 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 8 Oct 2024 · Status Ongoing, recruiting · 7 EU/EEA countries · 53 sites · Protocol 20210033

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 885
Countries 7
Sites 53

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Key facts

Sponsor
Amgen Inc.
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Respiratory Tract Diseases [C08]
Trial duration
8 Oct 2024 → ongoing
Decision date (initial)
2025-02-10
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-514304-14-00
WHO UTN
U1111-1303-1076
ClinicalTrials.gov
NCT06311721

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

VersionLevelCodeTermSystem organ class
20.0 LLT 10079440 Non-squamous non-small cell lung cancer 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Amgen Inc.

Sponsor organisation
Amgen Inc.
Address
1 Amgen Center Drive
City
Thousand Oaks
Postcode
91320-1799
Country
United States

Scientific contact point

Organisation
Amgen Inc.
Contact name
Medical Information

Public contact point

Organisation
Amgen Inc.
Contact name
Medical Information

Locations

7 EU/EEA countries · 53 investigational sites

By country

CountryMS statusPlanned subjectsSites
Austria Ended 12 3
Bulgaria Ongoing, recruiting 7 3
France Ongoing, recruiting 14 9
Germany Ended 30 7
Italy Ongoing, recruiting 53 9
Poland Ongoing, recruiting 60 6
Spain Ongoing, recruiting 57 16
Rest of world
Japan, Argentina, Philippines, Serbia, Turkey, Georgia, Thailand, Chile, Brazil, United States, Peru, United Kingdom, Korea, Republic of, Malaysia, Mexico, Taiwan
652

Investigational sites

Austria

3 sites · Ended
Landeskrankenanstalten-Betriebsgesellschaft Kabeg
Department of pulmonary diseases, Feschnigstrasse 11, Klagenfurt,09.Bez.:Annabichl, Klagenfurt Am Woerthersee
Ordensklinikum Linz GmbH
Pneumology, Fadingerstrasse 1, 4020, Linz
Klinik Hietzing
Klinik Hietzing 5. Med. Abteilung Pavillon 3, Wolkersbergenstrasse 1, Hietzing, Vienna

Bulgaria

3 sites · Ongoing, recruiting
Multiprofile Hospital For Active Treatment Dobrich AD
Department of Medical Oncology, Ulitsa Panayot Hitov 24, 9300, Dobrich
University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD
Department of Medical Oncology, Boulevard Akademik Ivan Evstratiev Geshov 15, 1431, Sofia
UMHAT Sofiamed OOD
Department of Medical Oncology, Bulevard D-R G.m.dimitrov 16, 1797, Sofiya

France

9 sites · Ongoing, recruiting
Hopital Europeen Marseille
Pneumology, 6 Rue Desiree Clary, 13003, Marseille
Centre Hospitalier Et Universitaire De Limoges
Pneumology, 2 Avenue Martin Luther King, 87042, Limoges Cedex 1
Centre Hospitalier Universitaire De Bordeaux
Medical Oncology, 1 Rue Jean Burguet, 33000, Bordeaux
Assoc Hospitaliere Nord Artois Clinique
Pneumology, 118 Avenue Desandrouin, 59300, Valenciennes
Hopitaux Prives De Metz
Pneumology, Parvis Schuman Rue Champs Montoy, Rue Pre Montois, Vantoux
Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer
Pneumology, 54 Rue Henri Sainte Claire Deville, 83100, Toulon
Centre De Cancerologue Du Grand Montpellier
Pneumology, 25 Rue De Clementville, 34070, Montpellier
Centre Hospitalier Universitaire De Nantes
Oncology thoracic Unit, Boulevard Du Professeur Jacques Monod, 44800, Saint Herblain
Centre Hospitalier Universitaire De Nimes
Oncology, 4 Place Du Professeur Robert Debre, Bp 40026, Nimes Cedex 9

Germany

7 sites · Ended
Friedrich-Ebert-Krankenhaus Neumuenster GmbH
Klinik Hämatologie, Onkologie und Nephrologie, Friesenstrasse 11, Innenstadt, Neumuenster
Klinikum St Marien Amberg
N/A, Mariahilfbergweg 7, 92224, Amberg
Klinikum Aschaffenburg-Alzenau gGmbH
N/A, Am Hasenkopf 1, Innenstadt, Aschaffenburg
KEM I Evang. Kliniken Essen-Mitte gGmbH
Klinik für Internistische Onkologie &Onkologische Palliativmedizin, Henricistrasse 92, Huttrop, Essen
Justus-Liebig-Universitaet Giessen
Hämatologie und Internistische Onkologie, Gaffkystrasse 5, 35392, Giessen
Dr. Vehling-Kaiser MVZ GmbH
N/A, Achdorfer Weg 5, Achdorf, Landshut
Onkologie UnterEms
N/A, Annenstr. 11, 26789, Leer

Italy

9 sites · Ongoing, recruiting
University Hospital Of Ferrara
UO Oncologia, Cona, Via Aldo Moro 8, Ferrara
Azienda Sanitaria Locale Napoli 1 Centro
UOC Oncologia, Via Enrico Russo 1, 80147, Naples
Azienda Socio Sanitaria Territoriale Della Valtellina E Dell Alto Lario
SC Oncologia Medica, Via Stelvio N 25, 23100, Sondrio
Azienda Ospedaliera S Maria Di Terni
S.C. Oncologia Medica, Viale Tristano Di Joannuccio 1, 05100, Terni
Azienda Unita Sanitaria Locale Della Romagna
UO Oncologia, Dipartimento Onco-Ematologico, Viale Vincenzo Randi 5, 48121, Ravenna
San Camillo Forlanini Hospital
UOSD Pneumo- oncologia, Circonvallazione Gianicolense 87, 00152, Rome
Azienda Socio Sanitaria Territoriale Di Cremona
Oncologia, Viale Concordia 1, 26100, Cremona
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
SC Oncologia Medica, Via Della Commenda 12, 20122, Milan
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
UOC Oncoematologia, Via Sergio Pansini 5, 80131, Naples

Poland

6 sites · Ongoing, recruiting
Centrum Onkologii Im. Prof. Franciszka Lukaszczyka W Bydgoszczy
Ambulatorium Chemioterapii I, Ul. Izabeli Romanowskiej 2, 85-796, Bydgoszcz
Wojewodzki Szpital Specjalistyczny Im. Janusza Korczaka W Slupsku Sp. z o.o.
Oddział Onkologii Klinicznej, Chemioterapii, Ul. Hubalczykow 1, 76-200, Slupsk
Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M. I M. Nastaj. sp.p.
N/A, Ul. Polnocna 8/3, 20-064, Lublin
Uniwersytecki Szpital Kliniczny Nr 4 W Lublinie
Kliniczny Oddzial Pneumonologii, Alergologii, Onkologii Pulmonologicznej i Chorob Wewnetrznych, Ul. Dra Kazimierza Jaczewskiego 8, 20-090, Lublin
Med Polonia Sp. z o.o.
not applicable/nie dotyczy, Obornicka 262, 60-693, Poznan
Warminsko-Mazurskie Centrum Chorob Pluc W Olsztynie
Oddzial onkologii z pododdzialem chemioterapii, Ul. Jagiellonska Nr 78, 10-357, Olsztyn

Spain

16 sites · Ongoing, recruiting
Hospital Quironsalud Barcelona
Oncology, Placa D'alfonso Comin 5-7, 08023, Barcelona
Micancer Center S.L.P.
Oncology, Calle Del Doctor Roux 76 Planta 5, 08017, Barcelona
Hospital General Universitario De Elche
Oncology, Edificio 2, Camino De La Almazara 11, Elche
Hospital Quironsalud Valencia
Oncology, Avenida Blasco Ibanez 14, 46010, Valencia
Hospital Universitario Central De Asturias
Oncology, Avenida De Roma S/n, 33011, Oviedo
Hospital Quironsalud Malaga
Oncology, Avenida Imperio Argentina 1, 29004, Malaga
Hospital Universitario Fundacion Alcorcon
Oncology, Calle Budapest 1, 28922, Alcorcon
Hospital Universitario De Jaen
Oncology, Avenida Del Ejercito Espanol 10, 23007, Jaen
Hospital Clinico Universitario De Valladolid
Oncology, Avenida Ramon Y Cajal 3, 47003, Valladolid
Hospital Universitario Virgen De Valme
Oncology, Avenida Bellavista S/n, 41014, Sevilla
Hospital Clinico San Carlos
Oncology, Calle Del Profesor Martin Lagos Sn, 28040, Madrid
Instituto Multidisciplinar De Oncologia S.A.
Oncology, Calle De Joaquin Costa 28, 28002, Madrid
Hospital Universitario Y Politecnico La Fe
Oncology, Avenida De Fernando Abril Martorell 106, 46026, Valencia
University Hospital Virgen Del Rocio S.L.
Oncology, Avenida De Manuel Siurot S/n, 41013, Sevilla
Consorci Sanitari Del Maresme
Oncology, Carretera De Cirera 230, 08304, Mataro
Hospital Universitario Fundacion Jimenez Diaz
Oncology, Avenida De Los Reyes Catolicos 2, 28040, Madrid

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Austria 2025-04-08 2025-07-01
Bulgaria 2024-10-28 2025-02-04
France 2024-10-14 2025-02-12
Germany 2024-11-05
Italy 2025-01-16 2025-08-25
Poland 2024-10-16 2025-02-18
Spain 2024-10-08 2024-10-17

Application history

9 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-05-31 Spain Acceptable
2024-09-23
2024-09-25
2 SUBSTANTIAL MODIFICATION SM-1 2024-10-25 Spain Acceptable 2024-11-08
3 SUBSTANTIAL MODIFICATION SM-3 2024-10-25 Acceptable 2024-12-09
4 SUBSTANTIAL MODIFICATION SM-2 2024-10-28 Acceptable 2024-12-13
5 SUBSTANTIAL MODIFICATION SM-4 2024-10-29 Acceptable 2024-12-03
6 SUBSTANTIAL MODIFICATION SM-5 2024-10-29 Acceptable 2025-02-07
7 SUBSEQUENT ADDITION OF MSC APP-7 2024-10-30 Acceptable
2024-09-23
2025-02-10
8 SUBSTANTIAL MODIFICATION SM-6 2025-04-18 Spain Acceptable
2025-07-17
2025-07-17
9 SUBSTANTIAL MODIFICATION SM-7 2025-10-15 Spain Acceptable
2026-02-02
2026-02-03